Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DSL
8326
DoubleLine Income Solutions Fund
DSL
$1.23B
| $402K | ﹤0.01% |
33,763
+10,058
| +42% | +$117K |
|
8327
CALL
Interface
TILE
$2.21B
| $402K | ﹤0.01% |
45,700
+2,300
| +5% | +$17.6K |
|
8328
PUT
EVgo
EVGO
$478M
| $402K | ﹤0.01% |
100,400
+27,100
| +37% | +$138K |
|
8329
CALL
Jakks Pacific
JAKK
$291M
| $401K | ﹤0.01% |
20,100
+14,800
| +279% | +$321K |
|
8330
IQ Candriam US Mid Cap Equity ETF
IQSM
$343M
| $401K | ﹤0.01% |
+14,142
| New | +$380K |
|
8331
CALL
First Trust Health Care AlphaDEX Fund
FXH
$1.13B
| $401K | ﹤0.01% |
3,700
+3,100
| +517% | +$332K |
|
8332
CALL
Zentalis Pharmaceuticals
ZNTL
$275M
| $401K | ﹤0.01% |
14,200
-100
| -0.7% | -$2.4K |
|
8333
iShares International Equity Factor ETF
INTF
$3.75B
| $401K | ﹤0.01% |
+14,940
| New | +$400K |
|
8334
PUT
Steven Madden
SHOO
$3.4B
| $399K | ﹤0.01% |
12,200
+2,000
| +20% | +$66.7K |
|
8335
Invesco RAFI Strategic US ETF
IUS
$962M
| $399K | ﹤0.01% |
9,838
-15,216
| -61% | -$591K |
|
8336
CALL
Excelerate Energy
EE
$1.14B
| $398K | ﹤0.01% |
19,600
-21,800
| -53% | -$455K |
|
8337
PUT
CorMedix
CRMD
$611M
| $398K | ﹤0.01% |
100,400
-8,800
| -8% | -$43.5K |
|
|
MPX
8338
CALL
DELISTED
Marine Products Corp
MPX
| $398K | ﹤0.01% |
23,600
-1,400
| -6% | -$20.7K |
|
8339
PUT
Black Hills Corp
BKH
$5.63B
| $398K | ﹤0.01% |
6,600
-4,200
| -39% | -$266K |
|
8340
CALL
Daktronics
DAKT
$945M
| $397K | ﹤0.01% |
62,100
+3,500
| +6% | +$20.5K |
|
8341
CALL
Vanguard FTSE Pacific ETF
VPL
$8.54B
| $397K | ﹤0.01% |
5,700
-8,200
| -59% | -$566K |
|
8342
CALL
HNI Corp
HNI
$3.45B
| $397K | ﹤0.01% |
14,100
+7,100
| +101% | +$189K |
|
|
NSPL
8343
DELISTED
NightShares 500 1x/1.5x ETF
NSPL
| $397K | ﹤0.01% |
+11,371
| New | +$375K |
|
8344
StealthGas
GASS
$355M
| $397K | ﹤0.01% |
93,239
-28,328
| -23% | -$85.8K |
|
8345
BioAtla
BCAB
$5.01M
| $397K | ﹤0.01% |
2,648
-7,605
| -74% | -$1.31M |
|
8346
Caesarstone
CSTE
$116M
| $397K | ﹤0.01% |
75,759
-15,003
| -17% | -$68K |
|
|
FOLD
8347
CALL
DELISTED
Amicus Therapeutics
FOLD
| $397K | ﹤0.01% |
31,600
-4,100
| -11% | -$48.7K |
|
|
EU
8348
enCore Energy
EU
$216M
| $397K | ﹤0.01% |
164,641
+137,785
| +513% | +$308K |
|
8349
PUT
Ultragenyx Pharmaceutical
RARE
$2.55B
| $397K | ﹤0.01% |
8,600
-800
| -9% | -$37.1K |
|
8350
CALL
Amphastar Pharmaceuticals
AMPH
$912M
| $397K | ﹤0.01% |
6,900
+1,200
| +21% | +$53.2K |
|
Similar funds
Citadel Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.
- Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
- Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Citadel Advisors opened 1,205 new positions and closed 1,562 in Q2 2023.
- Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.